Evaluation of safety and effectiveness of Eczacin cream in improving atopic dermatitis
Phase 2
Recruiting
- Conditions
- Atopic dermatitis.Atopic dermatitis
- Registration Number
- IRCT20210130050179N2
- Lead Sponsor
- Sina pharmed salamat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
Chronic or recurrent eczema with a mild to moderate severity and personal or family history of Atopia or high IgE level
Signing the consent form for participation in the study
Minimum score of one for the SCORAD (Severity Scoring of Atopic Dermatitis index) scale of redness and itching
Exclusion Criteria
Not to use topical medications for Atopic Dermatitis (except for moisturizer) in the last 2 weeks or systemic medications in the last 4 weeks. Use of steroids or systemic immunosuppressive drugs with any indication.
Pregnancy or lactating
Severe atopic dermatitis (SCORAD above 12)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal SCORAD (Severity Scoring of Atopic Dermatitis index) criteria. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Research physician will perform clinical assessments according to the local SCORAD (Severity Scoring of Atopic Dermatitis index) grade.
- Secondary Outcome Measures
Name Time Method Trans epidermal water loss. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Tewameter.;Stratum corneum hydration. Timepoint: Before intervention and 2 and 4 weeks after treatment. Method of measurement: Corneometer.